Biomarkers in Oncology
Springer-Verlag New York Inc.
978-1-4614-8315-1 (ISBN)
A powerful tool for determining decisions on therapy, selecting drug regimens, monitoring the efficacy of treatment, and performing individualized surveillance, biomarkers represent the forefront of cancer research and treatment. As these technologies become increasingly available for clinical use, this book will be an essential resource for oncologists and translational researchers.
Heinz-Josef Lenz, MD, FACP, Division of Medical Oncology, Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, CA 90033
1. Predictive Markers in Colon Cancer.- 2. Prognostic Markers in Breast Cancer.- 3. Predictive Markers in Lung Cancer.- 4. Prostate Cancer: Predictive Markers in Clinical Development.- 5. Biomarkers in GIST.- 6. Cytogenetic and Molecular Aberrations as Predictive Biomarkers in Acute Myeloid Leukemia.- 7. Prognostic Markers in Colon Cancer.- 8. Markers in Lung Cancer.- 9. Molecular Markers of Prostate Cancer Outcome.- 10. Prediction of Chemotherapy Toxicities.- 11. Surrogate Markers—The Role of Positron Emission Tomography Scanning.- 12. Circulating Tumor Cells as Biomarkers.- 13. Focus on Personalized Molecular Based Medicine.- 14. Clinical Validation of Biomarkers.- 15. Regulatory Issues.- 16. Biomarkers for Safety Assessment and Clinical Pharmacology.- 17. Biomarker Discovery Strategies: DNA, RNA and Protein.- 18. Biomarkers For Go/No Go Decisions.
Zusatzinfo | 37 Illustrations, color; 21 Illustrations, black and white; XVI, 447 p. 58 illus., 37 illus. in color. |
---|---|
Verlagsort | New York, NY |
Sprache | englisch |
Maße | 155 x 235 mm |
Themenwelt | Medizin / Pharmazie ► Medizinische Fachgebiete ► Onkologie |
Medizin / Pharmazie ► Pharmazie | |
Naturwissenschaften ► Biologie ► Biochemie | |
ISBN-10 | 1-4614-8315-8 / 1461483158 |
ISBN-13 | 978-1-4614-8315-1 / 9781461483151 |
Zustand | Neuware |
Haben Sie eine Frage zum Produkt? |
aus dem Bereich